Insmed reported $12.19M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.78M 0.45M
Alimera Sciences ALIM:US $ 1.68M 0.29M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Dynavax Technologies DVAX:US $ 39.96M 34.05M
Gilead Sciences GILD:US $ 1424M 1203M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Insmed INSM:US $ 12.19M 1.1M
Novartis NVS:US $ 3755M 245M
Regeneron Pharmaceuticals REGN:US $ 404.9M 577.7M
Sarepta Therapeutics SRPT:US $ 31.44M 0.3M
Seattle Genetics SGEN:US $ 87.63M 0.94M
Ultragenyx Pharmaceutical RARE:US $ 6.1M 2.59M
Vertex Pharmaceuticals VRTX:US $ 245.8M 1.59M